SEGLUROMET

This brand name is authorized in Austria, Australia, Cyprus, Estonia, Spain, Finland, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, United States

Active ingredients

The drug SEGLUROMET contains a combination of these active pharmaceutical ingredients (APIs):

1 Ertugliflozin
UNII MLU731K321 - ERTUGLIFLOZIN PIDOLATE

Ertugliflozin helps to lower blood glucose by making the patient pass out glucose in the urine. It does this by blocking a protein in the kidneys (called SGLT2) that normally takes glucose back into the blood from the kidneys.

Read about Ertugliflozin
2 Metformin
UNII 786Z46389E - METFORMIN HYDROCHLORIDE

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.

Read about Metformin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SEGLUROMET Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10BD23 Metformin and ertugliflozin A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD23

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 11562M, 11563N, 11564P, 11568W, 11569X, 11575F, 11581M, 11584Q
Country: EE Ravimiamet Identifier(s): 1767630, 1767641, 1767652, 1767663, 1767674, 1767685, 1767696, 1767708, 1767719, 1767720, 1767731, 1767742, 1767753, 1767764, 1767775, 1767786, 1767797, 1767809, 1767810, 1767821, 1767832, 1767843, 1767854, 1767865, 1767876, 1767887, 1767898, 1767900, 1777709, 1777710, 1777721, 1777732
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1181265011, 1181265025
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 088817, 459845, 489128, 511418
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8309, 8310
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1085295, 1085296, 1085297, 1085298, 1085299, 1085300, 1085301, 1085302, 1085303, 1085304, 1085305, 1085306, 1085307, 1085308, 1085309, 1085310, 1085311, 1085312, 1085313, 1085314, 1085315, 1085316, 1085317, 1085318, 1085319, 1085320, 1085321, 1085322, 1086580, 1086581, 1086582, 1086583
Country: NL Z-Index G-Standaard, PRK Identifier(s): 167711, 167738
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100403947, 100404668, 100404674, 100404680
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66529001, W66529002, W66529003, W66529004, W66530001, W66530002, W66530003, W66530004
Country: US FDA, National Drug Code Identifier(s): 0006-5369, 0006-5370, 0006-5373, 0006-5374

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.